Thanks to recent studies, no significant phenotype/genotype correlation could be shown between the phenotype and the mutation type and location or deletion size for either CREBBP or EP300 genes in RSTS patients [17,37,99,104]. This evidence concerns the gene CREBBP and Rubinstein-Taybi syndrome.